DaVita
DVA
#2053
Rank
A$13.83 B
Marketcap
A$206.92
Share price
2.46%
Change (1 day)
-6.09%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.45

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.14. In 2024 the company made an earnings per share (EPS) of A$15.41 an increase over its 2023 EPS that were of A$10.63.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.450.24%
2024A$15.4144.94%
2023A$10.6327.26%
2022A$8.35-35.56%
2021A$12.9644.1%
2020A$9.0019.7%
2019A$7.52540.48%
2018A$1.17-76.07%
2017A$4.90-19.31%
2016A$6.08242.52%
2015A$1.77-62.87%
2014A$4.7813.43%
2013A$4.218.45%
2012A$3.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$32.79 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.71 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$20.53 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.65-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA